Life history tradeoffs of pathogens and the treatment principle of antibiogenesis

Genes and Diseases

Volumn 4, Issue 3, 2017, Pages 154-158

  Wang, Rui An ^a  

^a SOUTHERN MEDICAL UNIVERSITY   (China)

Author keywords

Antibiogenesis; Bacterium; Fecundity; Infectious disease; Life history tradeoffs; Lifespan; Pathogen; Virus

Indexed keywords

VIRUS VECTOR;

ANTI-INFECTIVE THERAPY; BACTERIAL GROWTH; BACTERIAL INFECTION; BACTERIOPHAGE; BACTERIUM; CELL DEATH; CELL DIVISION; CHEMOTHERAPY; CLINICAL FEATURE; HEPATITIS VIRUS; INFECTIOUS AGENT; LIFE HISTORY; LIFESPAN; MALIGNANT NEOPLASM; MYCOBACTERIUM LEPRAE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PATHOLOGY; REVIEW; TREATMENT DURATION; VIRUS INFECTION;

EID: 85026641799     PISSN: 23524820     EISSN: 23523042     Source Type: Journal    
DOI: 10.1016/j.gendis.2017.07.004     Document Type: Review

References (23)

1. SC, S., The Evolution of Life Histories. 1992, Oxford University Press, London.
2. Fabian, D., Flatt, T., Life history evolution. Nat Educ Knowl, 3(10), 2012, 24.
3. Fabrizio, P., Gattazzo, C., Battistella, L., et al. Sir2 blocks extreme life-span extension. Cell 123:4 (2005), 655–667.
4. Partridge, L., Gems, D., Withers, D.J., Sex and death: what is the connection?. Cell 120:4 (2005), 461–472.
5. Kaeberlein, T.L., Smith, E.D., Tsuchiya, M., et al. Lifespan extension in Caenorhabditis elegans by complete removal of food. Aging Cell 5:6 (2006), 487–494.
6. Westendorp, R.G., Kirkwood, T.B., Human longevity at the cost of reproductive success. Nature 396:6713 (1998), 743–746.
7. Flatt, T., Heyland, A., Mechanisms of Life History Evolution. 2011, Oxford university Press.
8. Holmes, D.J., Fluckiger, R., Austad, S.N., Comparative biology of aging in birds: an update. Exp Gerontol 36:4-6 (2001), 869–883.
9. Goldhill, D.H., Turner, P.E., The evolution of life history trade-offs in viruses. Curr Opin Virol 8 (2014), 79–84.
10. Keen, E.C., Tradeoffs in bacteriophage life histories. Bacteriophage, 4(1), 2014, e28365.
11. Aktipis, C.A., Boddy, A.M., Gatenby, R.A., Brown, J.S., Maley, C.C., Life history trade-offs in cancer evolution. Nat Rev Canc 13:12 (2013), 883–892.
12. Wang, R.A., Ke, Z.Y., Liang, Y., Yang, T., Qin, J.H., Wang, L., Why is mycobacterium tuberculosis hard to grow? the principle of biorelativity explains. J Clin Exp Pathol, 4(3), 2014, 176.
13. Kane, M.A., Hadler, S.C., Lee, L., et al. The inception, achievements, and implications of the China GAVI alliance ppoject on hepatitis B immunization. Vaccine 31:Suppl 9 (2013), J15–J20.
14. Tong, S.P., Hepatitis B virus: sequence variability and evolution. Chin Bull Life Sci 28:3 (2016), 344–356.
15. Buckwold, V.E., Xu, Z., Chen, M., Yen, T.S., Ou, J.H., Effects of a naturally occurring mutation in the hepatitis B virus basal core promoter on precore gene expression and viral replication. J Virol 70:9 (1996), 5845–5851.
16. Moriyama, K., Okamoto, H., Tsuda, F., Mayumi, M., Reduced precore transcription and enhanced core-pregenome transcription of hepatitis B virus DNA after replacement of the precore-core promoter with sequences associated with e antigen-seronegative persistent infections. Virology 226:2 (1996), 269–280.
17. Parekh, S., Zoulim, F., Ahn, S.H., et al. Genome replication, virion secretion, and e antigen expression of naturally occurring hepatitis B virus core promoter mutants. J Virol 77:12 (2003), 6601–6612.
18. Tsai, A., Kawai, S., Kwei, K., et al. Chimeric constructs between two hepatitis B virus genomes confirm transcriptional impact of core promoter mutations and reveal multiple effects of core gene mutations. Virology 387:2 (2009), 364–372.
19. Baumert, T.F., Rogers, S.A., Hasegawa, K., Liang, T.J., Two core promotor mutations identified in a hepatitis B virus strain associated with fulminant hepatitis result in enhanced viral replication. J Clin Invest 98:10 (1996), 2268–2276.
20. Ito, K., Yotsuyanagi, H., Yatsuhashi, H., et al. Risk factors for long-term persistence of serum hepatitis B surface antigen following acute hepatitis B virus infection in Japanese adults. Hepatology 59:1 (2014), 89–97.
21. Kobayashi, M., Suzuki, F., Arase, Y., et al. Infection with hepatitis B virus genotype A in Tokyo, Japan during 1976 through 2001. J Gastroenterol 39:9 (2004), 844–850.
22. Imamura, T., Yokosuka, O., Kurihara, T., et al. Distribution of hepatitis B viral genotypes and mutations in the core promoter and precore regions in acute forms of liver disease in patients from Chiba, Japan. Gut 52:11 (2003), 1630–1637.
23. Zhang, H.W., Yin, J.H., Li, Y.T., et al. Risk factors for acute hepatitis B and its progression to chronic hepatitis in Shanghai, China. Gut 57:12 (2008), 1713–1720.